Disclosures for "Altered CSF Pseudo-diffusivity in Preterm Infants with Intra-Ventricular Hemorrhage"
-
Dr. Hosseini has nothing to disclose.
-
Dr. Limbrick has received personal compensation for serving as an employee of Rhaeos, Inc.. Dr. Limbrick has stock in Deepsight, Inc.. The institution of Dr. Limbrick has received research support from NIH/NINDS. The institution of Dr. Limbrick has received research support from Department of Defense.
-
Dr. Strahle has nothing to disclose.
-
The institution of Dr. Warner has received research support from NIH.
-
Mr. Reinhold has nothing to disclose.
-
Mr. Morales has nothing to disclose.
-
Ms. Meehan has nothing to disclose.
-
Mrs. Linneman has nothing to disclose.
-
Mr. Alexopoulos has nothing to disclose.
-
Mr. Loseille has nothing to disclose.
-
Mr. Gardner has nothing to disclose.
-
Dr. Smyser has nothing to disclose.
-
Dr. Nazeri has nothing to disclose.